Stimulant Use and Viral Suppression in the Era of Universal Antiretroviral Therapy
- 1 January 2019
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 80 (1) , 89-93
Abstract
Background: HIV-positive persons who use stimulants such as methamphetamine experience difficulties navigating the HIV care continuum that undermine the benefits of antiretroviral therapy (ART). However, few studies have examined the association of stimulant use with viral suppression in the era of universal ART. Setting: Zuckerberg San Francisco General Hospital. Methods: HIV-positive persons participating in a clinical cohort study and taking ART completed assessments every 4–6 months. The exposure was the cumulative, time-varying proportion of assessments with any self-reported stimulant use. The time-varying outcome, HIV viral suppression (ie, + T-cell count of 409 (IQR = 225–640) cells/mm3 at enrollment. Significant increases in odds of viral suppression over time were less pronounced among stimulant users compared with nonusers, particularly before the advent of universal ART. Increasing odds of viral suppression were paralleled by declining stimulant use over time. In the universal ART era, increasing odds of viral suppression were observed at lower levels of stimulant use, but not when participants reported using stimulants at every visit. Conclusions: Although ART benefits are still not achieved as rapidly in stimulant users, this disparity is not as large in the era of universal ART.Keywords
This publication has 29 references indexed in Scilit:
- Engagement in HIV Medical Care and Technology Use among Stimulant-Using and Nonstimulant-Using Men who have Sex with MenAIDS Research and Treatment, 2013
- The Effect of a "Universal Antiretroviral Therapy" Recommendation on HIV RNA Levels Among HIV-Infected Patients Entering Care With a CD4 Count Greater Than 500/ L in a Public Health SettingClinical Infectious Diseases, 2012
- Prevention of HIV-1 Infection with Early Antiretroviral TherapyNew England Journal of Medicine, 2011
- Crystal methamphetamine injection predicts slower HIV RNA suppression among injection drug usersAddictive Behaviors, 2011
- Psychiatric correlates of HAART utilization and viral load among HIV-positive impoverished personsAIDS, 2011
- Psychiatric Risk Factors for HIV Disease Progression: The Role of Inconsistent Patterns of Antiretroviral Therapy UtilizationJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based studyThe Lancet, 2010
- Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive womenAIDS, 2008
- Internalized heterosexism among HIV-positive, gay-identified men: Implications for HIV prevention and care.Journal of Consulting and Clinical Psychology, 2008
- Affect Regulation, Stimulant Use, and Viral Load Among HIV-Positive Persons on Anti-Retroviral TherapyPsychosomatic Medicine, 2007